Home
About us
Products
- Products
- ICOres
- ICOcap
- ICOpre
- ICOone
- Patents
Capabilities
Collaborations
Investors
News
Contact
Search
Menu Menu

Erbjudandet i Iconovo övertecknat inför börsnotering på First North (only in Swedish)

Erbjudandet i Iconovo övertecknat inför börsnotering på First North. Pressrelease_Iconovo 2018-03-26

March 26, 2018/by Mea Lindsjö

Share this entry

Share on Twitter
Share on LinkedIn
Share by Mail

https://iconovo.se/wp-content/uploads/2021/03/Breathtaking-innovation_Iconovo.png 0 0 Mea Lindsjö https://iconovo.se/wp-content/uploads/2021/03/Breathtaking-innovation_Iconovo.png Mea Lindsjö2018-03-26 17:36:562018-03-26 17:36:56Erbjudandet i Iconovo övertecknat inför börsnotering på First North (only in Swedish)

Possessing a unique combination

of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.

ICONOVO AB

VISITING ADDRESS
Medicon Village, Lund
Scheeletorget 1, Bld 406

POSTAL ADDRESS
Iconovo AB
Medicon Village
SE-223 81 LUND
Sweden

CONTACT

Phone: +46 46 275 67 77

VP Business Development
Roger Lassing
Mail: roger.lassing@iconovo.se

CEO
Johan Wäborg
Mail: johan.waborg@iconovo.se

SITEMAP

Home
Capabilities
Investors

Press releases

Interview with Dr. Orest Lastow, CEO Iconovo (only in Swedish) Iconovo to Nasdaq first North

Scroll to top